Abbott (NYSE:ABT) today shared new clinical trial findings supporting its Aveir AR leadless atrial pacemaker system.
Cardiology, well into the age of leadless pacemakers, could be headed for an age of leadless pacemaker systems in which various pacing functions are achieved by multiple implants that "talk" to each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results